Background: To evaluate the clinical association of extrastructurally abnormal chromosomes (ESACs) with pregnancy outcome based on the cytogenetic characteristics of the ESACs. Methods: We retrospectively reviewed 12 ESAC cases identified from 12,991 cases who received genetic amniocentesis between January 1983 and March 2008. Prenatal ultrasound findings, characteristics of ESACs (karyotypes, special features, origin, inheritance) and pregnancy outcomes were recorded. Results: The prenatal prevalence of ESACs was 0.092% (12/12,991). Of the 12 ESAC cases, all were de novo. Seven (58.3%) originated from nonacrocentric chromosomes and the other 5 (41.7%) were from acrocentric chromosomes, with 3 originating from chromosome 15. Six of the 12 cases (50%) were large ESACs; however, the other 6 (50%) were medium to small ESACs. All acrocentric ESACs contained dicentric and bisatellite characteristics. Using FISH and SKY techniques, the origins of 2 cases (patients 10 and 12) were clearly identified to be from chromosomes 15 and 10, respectively. Five of the 12 ESAC cases (41.7%) had congenital anomalies found by prenatal ultrasound. All were nonacrocentric in origin that were medium (1/5) to large (4/5) in size. After prenatal genetic counseling, 8 of the 12 (66.7%) couples opted to terminate the pregnancy. The other 4 (33.3%) continued the pregnancy and their babies were delivered at term normally and were followed-up, with normal development ranging from 2 to 17 years. Conclusion: With sophisticated cytogenetic characterization and ultrasound examination, it is possible to precisely categorize most fetuses with ESACs as being either at high risk of abnormality or at a relatively low risk. [J Chin Med Assoc 2009;72(1):29-33] 
Introduction
Extrastructurally abnormal chromosomes (ESACs) are a heterogeneous group. They have been described variously as markers, supernumeraries, accessories, and B-chromosomes. 1 Some are harmless and are associated with phenotypic normality (the B-chromosome), but others may pose a risk for the fetus. ESACs are encountered in about 1 in 1,000 prenatal diagnoses, frequently in the mosaic state with a normal cell line. [1] [2] [3] [4] [5] More than 50% of ESACs are acrocentric in origin, and idic(15), commonly referred to as inv dup(15), is the most common type. 4 Owing to their diverse origin and variable euchromatin content, the phenotypes associated with ESACs vary significantly. This variability poses a great dilemma for genetic counselors when an ESAC is detected during prenatal diagnosis because prediction of the pregnancy outcome is difficult. Warburton reported 123 occurrences of prenatally diagnosed ESAC cases and estimated that the phenotypic risk associated with acrocentric origin was 10.9% and that with nonacrocentric origin was 14.7%. 6 Recently, the contribution of molecular cytogenetic analyses (e.g. fluorescence in situ hybridization [FISH] and spectral karyotyping [SKY] ) have offered the possibility of rapid identification of the origin and nature of ESACs, which improves the prediction of clinical outcome during prenatal genetic counseling.
In this study, we retrospectively reviewed cases of ESACs detected prenatally in our institution between January 1983 and March 2008, and attempted to evaluate the clinical association of the ESACs with clinical outcomes based on the cytogenetic characteristics of the ESACs. A review of the relevant literature was also done.
Methods
We retrospectively checked all cases who received amniocentesis and reviewed the 12 ESAC cases we found in Taichung Veterans General Hospital during the period between January 1983 and March 2008.
In situ amniotic fluid cell culture, harvest, and Giemsa-banding technique were performed according to the standard protocols. Twenty primary colonies were examined by standard analyses. If the available number of the colonies was fewer than 20, a total of 20 cells from both primary and trypsinized cultures were examined. True mosaicism was defined as abnormal cell lines with ESACs present in at least 2 independent cultures. Special stains, including C-and NOR-bands, were applied to each ESAC case. Additional studies performed with the fluorescent dye DPAI (4',6-diamidino-2-phenylindole) and SRY gene (sex-determining region on the Y chromosome) were individualized. Parents' karyotypes were determined in order to identify de novo or familial inheritance of the ESACs. In comparison with the long arm of chromosome 21 (21q), the ESACs were categorized as small (< 1/2 21q), medium, or large (> 21q).
FISH and/or SKY were performed in 2 recent cases (nos. 10 and 12 in Table 1 ) according to the manufacturer's protocol. For case 10 undergoing FISH, 2 centromeric probes (D15Z1, Vysis, Des Plaines, IL, USA; and D15Z4, Cytocell, Cambridge, UK) and probes for the Prader-Willi syndrome (SNRPN, Vysis) and Angelman syndrome (UBE3A, Cytocell) chromosome regions were adopted. For case 12, multicolor SKY paint and FISH with chromosome-specific alphoid satellite DNA probe for chromosome 10 (CEP10, Gael, Scotland, UK) were done.
Prenatal ultrasound findings were reviewed in all cases. Continuous follow-up was conducted for clinical data regarding pregnancy outcome. Before a decision was made to terminate or continue with the pregnancy, formal counseling was provided by a genetic counselor.
Results
The prenatal diagnoses of the 12 ESAC cases are summarized in Table 1 . The prenatal prevalence of ESACs was 0.092% (12/12,991). These cases comprised 3.17% (12/378) of all chromosomal disorders during the study period. The indications for genetic amniocentesis were advanced maternal age (8/12), fetal anomaly (2/12), parents' anxiety (1/12), and maternal serum test showing high-risk result (1/12). All 12 ESAC cases were de novo.
Conventional cytogenetics with G-banding technique showed true mosaicism of ESACs (47,N, + mar/ 46,N) in 8/12 cases (66.7%). The size of the ESACs in 6/12 cases (50%) was large; however, the other 6 (50%) were medium to small. Seven of the 12 ESACs (58.3%) originated from nonacrocentric chromosomes and the other 5 (41.7%) were derived from acrocentric chromosomes (D/G groups), with 3 originating from chromosome 15. The C-and NOR-banding studies revealed that all acrocentric ESACs contained dicentric and bisatellite characteristics. FISH results showed that case 10 originated from chromosome 15. The presence of signals for the Prader-Willi/ Angelman syndrome critical regions (SNRPN and UBE3A) was confirmed ( Figure 1) . SKY identified the ESAC in case 12 as originating from chromosome 10 ( Figure 2) .
Five of the 12 ESAC cases (41.7%) had congenital anomalies found by prenatal ultrasound. All of them were from nonacrocentric chromosomes, including 4/5 (80%) with large (cases 2, 4, 6, and 11) and 1/5 (20%) with medium (case 7) ESACs.
Four of the 12 (33.3%) babies were delivered at term normally. They were followed-up, with normal development ranging from 2 to 17 years. After prenatal genetic counseling, 8 of the 12 (66.7%) couples decided to terminate the pregnancy. Of the pregnancies that were terminated, 5 fetuses (cases 2, 4, 6, 7 and 11) had apparent congenital abnormalities found by prenatal ultrasound, 2 (cases 2 and 10) had largesized ESACs, and 1 (case 9) had 2 different ESACs. There were no gross abnormalities found in the 3 terminated fetuses with unremarkable prenatal sonographic findings. Postnatal investigations using abortus skin tissues and/or umbilical cord blood confirmed the prenatal diagnoses in all 8 terminated cases.
Discussion
The origin and genetic content (euchromatin or heterochromatin) of ESACs should be investigated. Traditionally, this requires the use of special stains, including C-bands for constitutive heterochromatin around the centromere and the distal end of the Y chromosome, NOR-bands for the nucleolus organizing region in the short arms of the acrocentric group (chromosomes 13, 14, 15, 21 and 22), and DAPI for the heterochromatin of chromosomes 9, 15 and Y differentially. Through these studies, we identified 5 acrocentric (dicentric and bisatellite) and 7 nonacrocentric (nonsatellite) ESACs. The origin of 3 acrocentric ESACs from chromosome 15 was confirmed due to the presence of positive DAPI stain (cases 1, 3, and 10); however, the presence of critical regions in these cases cannot be excluded without further evaluations.
Extrastructurally abnormal chromosomes
With the increasing sophistication of molecular cytogenetics (e.g. FISH and SKY), further precise characterization of ESACs is possible. Therefore, it has become easier to predict the phenotype-genotype correlations of ESACs. In FISH, about 80% are shown to be derived from the acrocentric chromosomes, most commonly from chromosomes 15 or 22, and often involve only the pericentromeric region and the satellites. 7 The SKY technique offers the possibility of rapid identification of the origin and nature of some ESACs. therefore terminated. The application of SKY in case 12 showed the origin of ESAC to be chromosome 10. The pregnancy continued to term because this ESAC was small and almost completely comprised of C-band-positive heterochromatic materials. With new modalities to supplant classical cytogenetics, such as array-CGH and chromosome specific-molecular rulers, it will be possible to fully characterize the genetic content and dosage of each ESAC and to potentially describe/predict the clinical phenotype for specific cases. 8 Replication banding is used primarily to identify inactive X chromatin. 5 Therefore, this technique could be used in a case of ESAC originating from the X chromosome to further predict the phenotype.
The unconfirmed origins of the other 8 ESACs in this study were investigated by conventional G-, C-, and NOR-banding techniques. Most of them occurred before the feasibility of FISH or SKY. Some hints were still present. Two acrocentric ESACs (cases 2 and 5) were expressed by negative DAPI stains, hence chromosome 15 was excluded as the origin. The other ESACs may have originated from chromosomes 9p, 16p, X or Y. Nevertheless, conventional techniques could help provide a basis for further investigations with molecular studies. This would effectively shorten the interval between prenatal diagnosis and genetic counseling.
Upon the discovery of an ESAC at prenatal diagnosis, parental chromosomes are required. In principle, a heterochromatic ESAC conveys a low risk, whereas an euchromatic ESAC may imply a high risk for phenotypic abnormality. 6 Given the wide range of cytogenetic heterogeneity, it is not surprising that there should be a wide phenotypic range, including normality. 5 The majority of harmless ESACs comprise acrocentric short arm and pericentromeric material or other autosomal pericentromeric chromatin. 9 Many ESACs are very small and prone to loss during cell division, which results in familial mosaicism. 10 When a parent has the ESAC in mosaic state, prediction for the fetus is more difficult. The chromosome could potentially be harmful, but the parent might be protected by a particular tissue distribution. 11 Mosaicism appears not to alter the risk of abnormality. Furthermore, those in whom fetal ultrasonographic anomaly has been detected are at high risk.
With cytogenetic characterization and prenatal ultrasound examination, it is possible to precisely categorize most fetuses with ESACs as being either at high risk of abnormality or at a relatively low risk.
The information can be clearly conveyed to the parents of affected fetuses by genetic counselors.
